Pfizer to acquire oncology specialist Medivation for $ 14 bn

Posted on:25 Aug 2016 09:34:58
Pfizer to acquire oncology specialist Medivation for $ 14 bn
25 August 2016 Current Affairs: The US-headquartered pharma major Pfizer Inc has entered into an agreement to acquire Medivation Inc, a biopharmaceutical company focused on developing and commercialising small molecules for oncology, for a total enterprise value of approximately $ 14 billion.

The merger will give a boost to Pfizer’s consolidation effort through a series of acquisitions, especially after its bid to take over Allergan Plc in a $150 billion deal late last year fell apart when the Obama administration prevented the proposed combination with new rules.

Monthly Current Affairs

Current Affairs Section

Daily Current Affairs Quiz

Subscribe to Current Affairs

Enter your email to get daily current affairs

Current Affairs 2018 May

27 MAY
NEWS
26 MAY
NEWS
25 MAY
NEWS
24 MAY
NEWS

Current Affairs 2018 April

30 APRIL
NEWS
29 APRIL
NEWS
28 APRIL
NEWS
27 APRIL
NEWS

Current Affairs 2018 March

31 MARCH
NEWS
30 MARCH
NEWS
29 MARCH
NEWS
28 MARCH
NEWS